Enter Sun Pharma for long term, says Sandeep Shenoy Sandeep Shenoy of Pioneer Investcorp told CNBC-TV18, ” Sun Pharmaceutical Industries  is a well-run company where the business models are not impeded, I don’t think the glitches make much of a problem on their business model. Any leader of a sector where there is a small stumble and you get a ... Read More »

The Goose with the Golden Eggs Once when a Lion was asleep, a little Once upon a time, a man and his wife had the good fortune to have a goose which laid a golden egg every day. Lucky though they were, they soon began to think they were not getting rich fast enough. They imagined that if the bird ... Read More »

Lupin submits fresh studies for two products suspended by EMA Drug firm LupinBSE 0.01 % has submitted fresh studies to the European Medicines Agency (EMA) for two products, which are among 700 generic drugs suspended by the health regulator due to flawed clinical trial data provided by GVK Bio. “The company has successfully conducted the new bio equivalence (BE) studies ... Read More »

Natco Pharma rallies on strong Q4FY15 results MUMBAI: Shares of midcap Natco Pharma surged over 4 per cent in early trade on the back of strong results for quarter ended March 2015. The company’s net profit surged 126.66 per cent in Jan-March quarter to Rs 54.4 crore as compared to a net profit of Rs 24 crore in the corresponding ... Read More »

The cockroach theory for self-development At a restaurant, a cockroach suddenly flew from somewhere and  sat on a lady. She started screaming out of fear. With a panic stricken face and trembling voice, she started jumping, with both her hands desperately trying to get rid of the cockroach. Her reaction was contagious, as everyone in her group also got panicky. ... Read More »

Three new diabetes drugs come under the scanner of US drug regulator  Three new type-2 diabetes medicines, two of which were recently launched in India, have come under the scanner of the US drug regulator for potential risk of causing acidosis that could require hospitalization. The US Food and Drug Administration (FDA) has warned medical professionals and patients that type-2 ... Read More »

US lawsuit puts generic drug imports from India under scanner WASHINGTON: A US class action lawsuit accusing India’s Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US. The problem of lack of compliance with US Food and Drug Administration (FDA) guidance and ... Read More »

Story of a girl and apple A lovely little girl was holding two apples with both hands. Her mum came in and softly asked her little daughter with a smile: my sweetie, could you give your mum one of your two apples? The girl looked up at her mum for some seconds, then she suddenly took a quick bite on ... Read More »

US pharma sector welcomes India’s intellectual property policy The US pharma sector has welcomed India’s recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed by the country’s pharma sector to US companies. Acknowledging the “measured and cautious approach” of India in responding to recent requests for compulsory licenses and ... Read More »

Glenmark Pharma receives US FDA approval for calcipotriene cream Glenmark Pharmaceuticals Inc., USA (Glenmark), a subsidiary of Glenmark Pharmaceuticals, Mumbai, has received tentative approval from United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex topical cream, 0.005 per cent of Leo Pharma A/S. Glenmark will market this product upon receiving final ... Read More »